Los mejores pediatras de Tratamiento de sangre de cordón umbilical — TOP-20 médicos

Dr. Lara is a passionate Honduran-born medical doctor with a Mexican heart. She earned her MD at the Catholic University of Honduras and has an Obesity Medicine post-graduate degree from Universidad Iberoamericana in Mexico City. She continued into a Masters in Applied Nutrition with a focus on research at Universidad Iberoamericana in Mexico City where her commitment to staying up-to-date and her passion for evidence-based medicine grew fonder.

She is member of the International Society for Stem Cell Application, SCOPE certified by the World Obesity Federation, and certified for Sport’s and Exercise Nutrition.

Besides her clinical experience within multiple hospital ER’s and private practice, Dr. Lara has vast experience within the Regenerative Medicine area, where her biggest determination is to positively impact lives of her patients. She has also experience in administrative areas within Mexico, where besides overseeing treatments, she is up-to-date with Mexican regulatory laws (COFEPRIS). Her passions involve medicine and sports where she has managed to combine both, in her professional world as well as within her personal life.

Education:

2010 - 2016 - National Medical University named after O.O. Bogomolets, specialty "Medical business"

2017 - completed an internship in the field of "Laboratory diagnostics"

2018 - Ukrainian Military Medical Academy, specialty "Dermatovenereology"

2021 - senior lecturer of the department of VZPSM on the course "Dermatovenereology", Ukrainian Military Medical Academy  

2021 - certified trainer in injection techniques

Since 2017 - dermatologist, cosmetologist at Mediland MC

Improving skills and acquiring new knowledge:

2017 - courses under the program "Cosmetologist, body esthetician" at the School of Cosmetology and Aesthetic Medicine "Partner +"

2017 - courses under the program "Specialist in injection techniques: mesotherapy, biorevitalization, botulinum therapy, contour plastic surgery"

2017 - participant of the III All-Ukrainian symposium Company of Cosmetology

2018 - course under the "Trichology" program

2018 - course under the program "Plasmotherapy"

2018 - course under the program "Contour plastic in aesthetic medicine"

2018 - course under the program "PRX-T33 - Injection-free dermal remodeling"

2018 - received training in laser techniques "Laser training on: Motus, MINISILK_FT, YNCHRO_FT"

2018 - participant of the 4th All-Ukrainian symposium "Company of Cosmetology"

2020 - "MEDfocus: dialogue of professionals" Modern approaches in dermatology and aesthetic medicine

2020 - "DERM SUMMIT" International scientific and practical virtual summit for doctors of all specialties and patients on dermatology issues

2021 - "Melanoma days 2021"

2021- "Acne, rosacea and chronic dermatoses of the face" as part of the 2021 Spring Symposium.

2021 - "Academy of Trichology"

2021 - "S-congress 3.0"

2021 - "Advanced dermatology: multifaceted possibilities and solutions"

2022 - academic readings named after Volodymyr Pask within the framework of the 31st International Medical Exhibition "PUBLIC HEALTH 2022"

2022 - "MELANOMA DAY 2022"

Is a valid member:

Ukrainian Association of Dermatologists and Cosmetologists UADVC

International Association of Aesthetic Cosmetology and Mesotherapy MAEKM

The doctor is an expert in the TV project "I am ashamed of my body" (STB channel) - he conducts consultations, diagnoses and treats patients, the heroes of the project.

Certified trainer in injection techniques of the MedHome company for Twac and Phillex drugs.Senior lecturer of the Department of the Ukrainian Academy of Medical Sciences for the course "Dermatovenereology", Ukrainian Military Medical Academy  

A trichologist, dermatologist diagnoses and treats such diseases of the skin of the face and body, nails and hair as:

acne skin irritations, acne, postacne

rosacea

demodicosis

seborrheic dermatitis

skin neoplasms - warts, papillomas, etc

alopecia or hair loss of various types (examination using a trichoscope and laboratory tests, prescription of conservative treatment, treatment using injection methods of treatment)

onychomycosis or nail fungus

other diseases of the skin of the face, body, hair

Performed procedures for diagnosis and treatment of dermatological diseases:

Dermatoscopy

Radiowave removal of skin neoplasms with the Surgitron device

Cryodestruction of skin neoplasms - warts, papillomas

Cryomassage of the skin of the face, body and scalp

Trichoscopy of the scalp and hair follicles

The doctor will draw up an individual comprehensive skin care program depending on the type of skin and its condition

The cosmetologist performs the following procedures:

Laser cosmetology:

laser epilation

laser grinding

photo rejuvenation

carbon peeling

Classical cosmetology:

mechanical cleaning of the face

ultrasonic face cleaning

chemical peels

facial massage

carboxytherapy

skin care procedures

comprehensive skin care programs

Hardware cosmetology:

procedures on "Futura PRO"

Ultrasonic facial massage

microcurrent

myostimulation of the face and body

biostimulation of the face and body

darsonval of the face and scalp

Injection cosmetology:

mesotherapy of the face, body and scalp / hair

biorevitalization

revitalization "Aquashine"

botulinum therapy

contour plastic

plasma lifting or PRP therapy

Cryotherapy:

cryomassage of the skin of the face, décolleté, back

cryomassage of the scalp

Jefe de Enseñanza Hospital Regional de Puerto Vallarta  

2020-2023

Encargada de expediente clínico en Hospital Regional de Puerto Vallarta 2 meses 2020  

Médico general en consultorio médico particular  

2015-2022  

Medico a cargo de clínica para control de peso  

2013-2014  

Asistente médico en clínica dermatológica

2008-2013 

 Asistente Medico en procedimientos Dermatológicos.  

 Asistente Medico en procedimientos quirúrgicos mínimo invasivos  

 Operación de máquina de laser fraccionado - IPIXEL-ER y  

rejuvenecimiento facial con  IPL.  

 Experiencia en depilación láser con Luz Pulsada Intensa  y  

radiofrecuencia  

 Experiencia con cavitación ultrasónica  

 Experiencia con máquina de fototerapia con luz ultravioleta (UV) para el  

tratamiento de psoriasis y vitíligo.    

 Experiencia asistiendo en procedimientos de Botox y Rellenos.  

 Biomagneta certificada por Instituto superior de biomagnetismo  

medico ISAAC GOIZ DURAN  

 Experiencia en expediente clínico    

 Capacitación en formación continua y desarrollo profesional docent

Kanokkaew Viravan , M.D.

General Pediatrician, American Board of Pediatrics

Graduated (M.D. From)

Doctor of Medicine from Medical University of South Carolina, SC, USA

Certificates

Diplomate of the American Board of Pediatrics, Pennsylvania State University Children’s Hospital, PA, USA

Diplomate of National Board of Medical Examiners from USA

Certificate in Fundamentals of Occupational and Environmental Medicine, Burapha University

Certificate of Actively Attended and Participated as DELEGATE at the FUE Asia, Thailand ASEAN Regional Workshop
(LIVE HAIR TRANSPLANT WORKSHOP) : 23-24 August 2024

Current Positions

General Pediatrician at Intrarat Hospital

Dr Supaporn Sompanwang, M.D.

General Pediatrician

Has Special training in preventing, diagnosing, and treating diseases and injuries in children. Pediatricians also help manage other problems that affect children, such as developmental disorders and behavioral, emotional, and social problems.

Graduated (M.D. From)

Doctor of Medicine, Faculty of Medicine, Naresuan University

Certificates

Certificate of Pediatrics, Buddhachinaraj Phitsanulok Hospital

Certificate of Family Medicine, Buddhachinaraj Phitsanulok Hospital

Current Positions

Pediatrician at Intrarat Hospital

Dr Panyapan Tiraprasidporn, M.D.

General Pediatrician

Special training in preventing, diagnosing, and treating diseases and injuries in children. Pediatricians also help manage other problems that affect children, such as developmental disorders and behavioral, emotional, and social problems.

Graduated (M.D. From)

Doctor of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University

Certificates

Certificate of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University

Current Positions

General Pediatrician at Intrarat Hospital

Education:

1977 - 1984 - Medical Institute, specialty "Medical business"

Improving skills and acquiring new knowledge:

1990 - Clinical residency in the specialty "Cycle therapy with clinical cardiology", Kyiv

1992 - TU "Medical Radiology", Kharkiv

1995 - TU "Modern methods of diagnosis of internal diseases and rheumatology", Kyiv

1999 - TU "Organization of Medical Support of the Armed Forces", Kyiv

2004 - TU "Current issues of clinical arrhythmology in cardiology", Kyiv

2009 - TU "Current issues of therapy and rheumatology", Kyiv

2012 - TU "Fundamentals of geriatric knowledge", Kyiv

2013 – Institute for Advanced Training of Managerial Personnel of the National Academy of Sciences under the President of Ukraine, Kyiv

2014 - TU "Current issues of therapy and pulmonology", Kyiv

2016 - Specialization "organization and management of health care", Kyiv

2018 - TU "Current issues of internal diseases of the patient", Kyiv

2020 - TU "Current issues of therapy", Kyiv

2021 - TU "Current issues of internal diseases of the patient", Kyiv

2023 - TU "Current issues - clinical cardiology", Kyiv

The main areas of practical activity:

examination, anamnesis study and consultations on the treatment of diseases of a therapeutic profile

appointment of the necessary additional examination

interpretation of analysis results

appointment of an individual treatment plan and recommendations for disease prevention

control of therapy, recovery and rehabilitation measures

Participation in associations:

Association of therapists of Ukraine

Association of Cardiologists of Ukraine

Association of Gastroenterologists of Ukraine

Organization of medical care in EU countries

Association of Physiotherapists ("Karlovo Vary", Prague)

The therapist treats the following diseases:

SARS

acute bronchitis

pneumonia

State Public Enterprise

acute vasomotor rhinitis

chronic gastroduodenitis

ulcer disease

chronic cholecystitis

pancreatitis

NCD

hypertensive disease

CHD

gout

gouty polyarthritis

acute cystitis

metabolic disorders, obesity

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education

• 2000, (Undergraduate / Graduate) Cerrahpaşa Faculty of Medicine, Istanbul University
• 2006, (PhD/ Specialty) Pediatrics, Istanbul Haydarpaşa Numune Training and Research Hospital

Experience

• 2001-2002, (Research Assistant) Istanbul Taksim First Aid Training and Research Hospital, Biochemistry Department
• 2002-2006, (Research Assistant) Istanbul Haydarpaşa Numune Training and Research Hospital
• 2006-2010, (Specialist) Bolu Izzet Baysal Women's Health and Pediatric Hospital
• 2010-2016, (Assistant Professor) Department of Pediatrics, Abant Izzet Baysal University Faculty of Medicine
• 2016, (Associate Professor) Department of Pediatrics, Abant Izzet Baysal University Faculty of Medicine
• 2018-2019, (Associate Professor) Istanbul Private Ersoy Hospital

2019-2024

, 

(Associate Professor)

 Istanbul Private Hisar Intercontinental Hospital

Education

GATA Haydarpaşa Training and Research Hospital Istanbul, Turkey

Residency program Sep 2011

Infectious Diseases and Clinical Microbiology Department fellowship program.

Gülhane Military Medical Academy Ankara, Turkey

Bachelor of Science: Medical School Aug 2003

Kuleli Military High School Istanbul, Turkey

High School Diploma Jul 1997

Experience

Health Sciences University Istanbul, Turkey

Associated Professor of Infectious Diseases Aug 2021 - Current

Associated Professor

Sisli Hamidiye Etfal Training and Research Hospital Istanbul, Turkey

Infectious Diseases Physician July 2020–August 2021

Infectious Diseases Physician

Yale School of Medicine Infectious Diseases Department New Haven, CT, USA

Associate Research Scientist June 2019- June2020

Research to improve vaccine against Tick Borne Diseases (Lyme Diseases, Babesiosis etc.)

Yale School of Medicine Infectious Diseases Department New Haven, CT, USA

Visiting Research Scientist Jul 2018 - June2019

Research to improve vaccine against Tick Borne Diseases (Lyme Diseases, Babesiosis etc.)

Turkish Ministry of Health Ankara, Turkey

Head of Health Tourism unit Feb 2017 - June 2018

Improving the health tourism policy of Turkey.

Sisli Hamidiye Etfal Training and Research Hospital Istanbul, Turkey

Infectious Diseases Physician Aug 2016 - June 2018

Infectious Diseases Physician

Tatvan Military Hospital Bitlis , Turkey

Infectious Diseases Physician Jul 2013 - Aug 2016

Infectious Diseases physician

Girne Military Hospital Turkish Republic of Northern Cyprus

Infectious Diseases Physician Oct 2011 - Jun 2013

Infectious diseases physician

GATA Training and Research Hospital Istanbul, Turkey

Residency period Jul 2006 - Sep 2011

4 th. Mechanized Infantry Brigade Command Edirne, Kesan, Turkey

Medical Doctor, May 2004 - Jun 2006

Maintaining the basic health services of the military unit.

El Prof. Nils Thoennissen es un especialista internacional en cáncer, enfermedades crónico degenerativas y medicina regenerativa con más de 20 años de experiencia en medicina basada en evidencia y 14 años de experiencia clínica en hemoterapia. Es autor de 40 publicaciones científicas en revistas revisadas por pares y ha sido galardonado con 6 premios. Ha recibido formación de posgrado en la Universidad de Münster, la Facultad de Medicina de la Universidad de Cardiff, la Universidad de Mainz y el Centro Médico Cedars-Sinai. Actualmente ocupa el cargo de director médico de CBC Health y ha ocupado cargos anteriores como médico jefe en el Hospital St. George, el Centro Médico Kloster Paradies y el Centro Médico Universitario Hamburg-Eppendorf.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA

ESPECIALISTA EN MEDICINA REGENERATIVA Y ANTIENVEJECIMIENTO.

TRATAMIENTO DE ENFERMEDADES DEGENERATIVAS.

TERAPIAS ANTIENVEJECIMIENTO MEDIANTE USO DE CELULAS MADRE, DERIVADOS, TERAPIA DE REEMPLAZO HORMONAL Y SUEROTERAPIA.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA

ESPECIALISTA EN MEDICINA REGENERATIVA Y ANTIENVEJECIMIENTO.

TRATAMIENTO DE ENFERMEDADES DEGENERATIVAS.

TERAPIAS ANTIENVEJECIMIENTO MEDIANTE USO DE CELULAS MADRE, DERIVADOS, TERAPIA DE REEMPLAZO HORMONAL Y SUEROTERAPIA.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA

ESPECIALISTA EN MEDICINA REGENERATIVA Y ANTIENVEJECIMIENTO.

TRATAMIENTO DE ENFERMEDADES DEGENERATIVAS.

TERAPIAS ANTIENVEJECIMIENTO MEDIANTE USO DE CELULAS MADRE, DERIVADOS, TERAPIA DE REEMPLAZO HORMONAL Y SUEROTERAPIA.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA

ESPECIALISTA EN MEDICINA REGENERATIVA Y ANTIENVEJECIMIENTO.

TRATAMIENTO DE ENFERMEDADES DEGENERATIVAS.

TERAPIAS ANTIENVEJECIMIENTO MEDIANTE USO DE CELULAS MADRE, DERIVADOS, TERAPIA DE REEMPLAZO HORMONAL Y SUEROTERAPIA.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA

ESPECIALISTA EN MEDICINA REGENERATIVA Y ANTIENVEJECIMIENTO.

TRATAMIENTO DE ENFERMEDADES DEGENERATIVAS.

TERAPIAS ANTIENVEJECIMIENTO MEDIANTE USO DE CELULAS MADRE, DERIVADOS, TERAPIA DE REEMPLAZO HORMONAL Y SUEROTERAPIA.

MIEMBRO ACTIVO DEL CONSEJO DE MEDICOS CIRUJANOS CON FINES DE INVESTIGACION.

MIEMBRO DEL CONSEJO MEXICANO DE CELULAS TRONCALES  CON FINES TERAPEUTICOS Y DE INVESTIGACION.

MIEMBRO DEL COLEGIO MEXICANO DE CELULAS MADRE Y MEDICINA REGENERATIVA.